These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8051627)

  • 21. [Accelerated breakdown of membrane phospholipids in schizophrenia--implications for the hypofrontality hypothesis].
    Gattaz WF; Brunner J; Schmitt A; Maras A
    Fortschr Neurol Psychiatr; 1994 Dec; 62(12):489-96. PubMed ID: 7835820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arachidonic acid liberation induced by phosphatidic acid endogenously generated from membrane phospholipids in rabbit platelets.
    Hashizume T; Taniguchi M; Sato T; Fujii T
    Biochim Biophys Acta; 1994 Mar; 1221(2):179-84. PubMed ID: 8148396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms governing the level of susceptibility of erythrocyte membranes to secretory phospholipase A2.
    Jensen LB; Burgess NK; Gonda DD; Spencer E; Wilson-Ashworth HA; Driscoll E; Vu MP; Fairbourn JL; Judd AM; Bell JD
    Biophys J; 2005 Apr; 88(4):2692-705. PubMed ID: 15681653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phospholipase activation and secretion: evidence that PLA2, PLC, and PLD are not essential to exocytosis.
    Coorssen JR
    Am J Physiol; 1996 Apr; 270(4 Pt 1):C1153-63. PubMed ID: 8928743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Asymmetric manipulation of the membrane lipid bilayer of intact human erythrocytes with phospholipase A, C, or D induces a change in cell shape.
    Fujii T; Tamura A
    J Biochem; 1979 Nov; 86(5):1345-52. PubMed ID: 521437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological intervention with platelet phospholipase A2.
    Nosal R; Jancinova V
    Bratisl Lek Listy; 2001; 102(10):447-53. PubMed ID: 11802290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heat-induced alterations in monkey erythrocyte membrane phospholipid organization and skeletal protein structure and interactions.
    Kumar A; Gudi SR; Gokhale SM; Bhakuni V; Gupta CM
    Biochim Biophys Acta; 1990 Dec; 1030(2):269-78. PubMed ID: 2261489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relevance of metabolism of membrane phospholipids for Alzheimer dementia].
    Gattaz WF; Levy R; Cairns NJ; Förstl H; Braus DF; Maras A
    Fortschr Neurol Psychiatr; 1996 Jan; 64(1):8-12. PubMed ID: 8850090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of phospholipase A2 treatment of human erythrocyte membranes on the rates of spectrin-actin dissociation.
    Gottlieb MH
    Biochim Biophys Acta; 1982 Mar; 686(1):133-6. PubMed ID: 7066319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roles of charged groups on the surface of membrane lipid bilayer of human erythrocytes in induction of shape change.
    Tamura A; Fujii T
    J Biochem; 1981 Sep; 90(3):629-34. PubMed ID: 7309693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Membrane phospholipid composition, fluidity and phospholipase A2 activity of human hepatoma cell line HepG2.
    Koumanov KS; Momchilova-Pankova AB; Wang SR; Infante R
    Int J Biochem; 1990; 22(12):1453-5. PubMed ID: 2177402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormalities in membrane phospholipid organization in sickled erythrocytes.
    Lubin B; Chiu D; Bastacky J; Roelofsen B; Van Deenen LL
    J Clin Invest; 1981 Jun; 67(6):1643-9. PubMed ID: 7240412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phospholipid organization in monkey erythrocytes upon Plasmodium knowlesi infection.
    Van der Schaft PH; Beaumelle B; Vial H; Roelofsen B; Op den Kamp JA; Van Deenen LL
    Biochim Biophys Acta; 1987 Jul; 901(1):1-14. PubMed ID: 3593720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Action of cobra venom phospholipase A2 toward lipids of erythrocyte membranes.
    Adamich M; Dennis EA
    Prog Clin Biol Res; 1979; 30():515-21. PubMed ID: 531042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulatory effect of phospholipase A2 treatment on glucose utilization in human erythrocytes.
    Miwa I; Duan YJ; Murase S; Fukatsu H; Tamura A; Okuda J
    Biochim Biophys Acta; 1993 Jan; 1175(2):174-80. PubMed ID: 8418896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deinhibition of cardiac Na+-K+-ATPase after exposure to exogenous phospholipase A2.
    Colvin RA
    Am J Physiol; 1987 Jan; 252(1 Pt 2):H32-9. PubMed ID: 3028163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in membrane phospholipid distribution during platelet activation.
    Bevers EM; Comfurius P; Zwaal RF
    Biochim Biophys Acta; 1983 Dec; 736(1):57-66. PubMed ID: 6418205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modification of the erythrocyte membrane by a non-specific lipid transfer protein.
    Franck PF; De Ree JM; Roelofsen B; Op den Kamp JA
    Biochim Biophys Acta; 1984 Dec; 778(3):405-11. PubMed ID: 6509044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transbilayer distributions of red cell membrane phospholipids in unilamellar vesicles.
    Kumar A; Gupta CM
    Biochim Biophys Acta; 1984 Jan; 769(2):419-28. PubMed ID: 6421319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-1-mediated phospholipid breakdown and arachidonic acid release in human synovial cells.
    Angel J; Colard O; Chevy F; Fournier C
    Arthritis Rheum; 1993 Feb; 36(2):158-67. PubMed ID: 8431204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.